BioPharma Services Newsletter
The Eurofins Group publishes a BioPharma Services newsletter, presenting new services and analytical techniques, research projects, major events and other related topics. The newsletter is published 3 times per year.
- Shedding light on phenotypic drug discovery to advance oncology efforts
- Improving cancer treatment with molecular diagnostics
- "One-stop" solution for biocidal products authorisation
- CRISPR/Cas - the system that revolutionises gene editing
- Self Emulsifying Drug Delivery Systems
- Eurofins Lancaster Labs’ newly opened building expansion
- Have a look at previous issues of the pharma newsletter.